Literature DB >> 6089248

Adrenergic-receptor desensitization and course of clinical improvement with desipramine treatment.

M L Mavroidis, D R Kanter, D N Greenblum, D L Garver.   

Abstract

alpha 2-Adrenergic receptor sensitivity was assessed during desipramine treatment by carefully monitoring clonidine-induced blood pressure changes, as well as symptomatology, in three patients with major depressive disorder. The data appear to be consistent with the hypothesis that the antidepressant action of desipramine is mediated by alpha 2-autoreceptor desensitization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089248     DOI: 10.1007/bf00464799

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  3 in total

Review 1.  Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.

Authors:  D S Charney; D B Menkes; G R Heninger
Journal:  Arch Gen Psychiatry       Date:  1981-10

2.  Antidepressants and alpha 2-adrenergic autoreceptor desensitization.

Authors:  L J Siever; R M Cohen; D L Murphy
Journal:  Am J Psychiatry       Date:  1981-05       Impact factor: 18.112

3.  Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment.

Authors:  D S Charney; G R Heninger; D E Sternberg; D E Redmond; J F Leckman; J W Maas; R H Roth
Journal:  Arch Gen Psychiatry       Date:  1981-12
  3 in total
  2 in total

Review 1.  Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

Authors:  G B Baker; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

2.  The effect of clonidine on plasma MHPG: evidence against tonic alpha 2-adrenoceptor control of noradrenergic function.

Authors:  D J Nutt; S G Molyneux
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.